May 15, 2026 20:23 ET | Source: Constellation Software Inc. TORONTO, May 15, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…
Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage…
May 15, 2026 09:00 ET | Source: Sana Biotechnology, Inc SEATTLE , May 15, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology,…
May 15, 2026 09:00 ET | Source: Vaso Corporation PLAINVIEW, N.Y., May 15, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”)…
La Hulpe, Belgium – 15 May 2026, 7:00 CET – INSIDE INFORMATION – Banqup Group SA, (Euronext: BANQ) (Banqup, Company),…
May 14, 2026 23:08 ET | Source: BERTO ACQUISITION CORP. II NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Berto…
May 14, 2026 22:00 ET | Source: FormFactor, Inc. LIVERMORE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq:…
CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company…
NEW YORK and PARIS, May 14, 2026 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies for early cancer…
100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission May 14, 2026 11:43 ET |…